EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Cilengitide limits syndromic and sporadic thoracic aortic aneurysm by targeting specific αV integrin

Sara Rega, Silvia Bouhuis, Maddalena Brusati, Tea Maverna, Nadia Fanotti, Manuel Casaburo, Simone Vodret, Francesco Riccitelli, Federico Celotto, Luca Lambroia, Montserrat Climent, Leonardo Elia, Martina Vescio, Linda Pattini, Rosaria Santoro, Veronika Myasoedova, Paolo Poggio, Giorgia Bonalumi, Nathasha Samali Udugampolage, Jacopo Taurino, Alessandro Pini, Serena Zacchigna, Giulio Pompilio, Gianluca L. Perrucci

Journal of Experimental Medicine · 2026-12-07 · 223 (12)

DOI: 10.1084/jem.20260700 ↗
AbstractBibliografische Angaben

Abstract

Thoracic aortic aneurysm (TAA) is one of the major causes of morbidity and mortality worldwide, still lacking an etiologic therapy. Aberrant activation of TGF-β and dysregulation of mechanotransduction signalling in vascular smooth muscle cells (VSMCs) play a key role in the pathology. However, a precise picture of molecular mechanisms in the disease is still unclear. Integrins containing the αV subunit are central in pro-fibrotic pathways mediated by TGF-β and mechanotransduction signalling pathways, but their role as a potential therapeutic target in syndromic and sporadic TAAs still needs investigation. We showed higher expression levels of αV integrin in both types of human TAAs and that the αV integrin inhibitor Cilengitide limits pro-fibrotic events in patient-derived VSMCs. In vivo results defined Cilengitide as the most effective and promising drug for the treatment of TAAs in humans.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →